Abstract
A third dose of COVID-19 vaccine should be offered to severely immunocompromised people to improve immunogenicity, the UK's Joint Committee on Vaccination and Immunisation (JCVI) advised on Sept 1, 2021. The decision followed similar announcements by the US Food and Drug Administration (FDA) and US Centers for Disease Control and Prevention (CDC) in August.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
